Sermorelin, also known as GRF 1-29, is a synthetic peptide containing the first 29 amino acids of endogenous Growth Hormone-Releasing Hormone (GHRH). This specific 29-amino acid sequence is recognized in scientific literature as the shortest functional fragment capable of fully binding to and activating the GHRH receptor.

Current laboratory and in-vitro applications focus on its mechanism as a secretagogue. Researchers utilize Sermorelin to observe the stimulation of somatotropic cells and the subsequent downstream effects on cellular growth, protein synthesis, and metabolic pathways. Unlike exogenous hormones, Sermorelin is frequently studied in research models to understand how native regulatory feedback loops operate, making it a foundational compound for studies related to cellular aging, neurogenesis, and metabolic regulation.